| Anika Therapeutics is joint preservation and regenerative therapies company. Co.'s Joint Pain Management Therapies product family includes MONOVISC, ORTHOVISC, CINGAL, and HYVISC, hyaluronic acid (HA)-based intraarticular injectable products. Co.'s Orthopedic Joint Preservation and Restoration Care products include HYALOFAST, TACTOSET, Arthrosurface's catalogue of over 150 partial and total joint surface implants and preservation solutions for the knee, shoulder, hip, ankle, wrist and toe and Parcus Medical's line of surgical implant and instrumentation solutions. Co.'s Other product family consists of HA-based products that do not fit into one of its other primary product categories. The ANIK YTD return is shown above.
The YTD Return on the ANIK YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ANIK YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ANIK YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.